The growth follows over $3 billion in new contracts to produce highly popular weight loss drugs.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
News
Accure Acne announces the appointment of Samuel Navarro to the Board
BOULDER, Colo., June 21, 2022 /PRNewswire/ — Accure Acne, Inc. announced today that Samuel E. Navarro has joined Accure Acne’s Board of Directors. Along with Chairman and Founder Christopher Carlton, Founder Ed Barbera, and Board […]
News
Olatec gets $40M to put anti-inflammatory in late-stage trial; Enliven goes public, raises $165M
A US and Dutch biotech closed its $40 million Series A to bankroll more studies of its oral anti-inflammatory drug. Olatec Therapeutics said the financing will fund a late-stage clinical trial of its drug, dapansutrile, an NLRP3 […]
News
CU Anschutz Researchers Develop Potential Nonhormonal Therapy to Repair Vaginal Tissue Damaged by Menopause
Researchers at the University of Colorado Anschutz have developed a promising nonhormonal therapy for women experiencing Genitourinary Syndrome of Menopause (GSM). GSM is a common chronic condition caused by declining estrogen levels that affects the […]
